Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.13 Analyst target: $11.12 Upside: 168.92%
CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company is headquartered in Rehovot, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.